-
Are you paying too much for neuropathy screening? Researchers at the University of Michigan found that less expensive, more effective tests are less likely to be used than the costlier ones. Almost one-quarter of patients receiving neuropathy diagnoses undergo high-cost, low-yield MRIs while very few receive low-cost, high-yield glucose tolerance tests, according to the study…